Literature DB >> 19332093

The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura.

Wei Ting Du1, Hai Feng Zhao, Jian Hui Xu, Dong Sheng Gu, Feng Xue, Jing Ge, Xun Wei Dong, Zhen Ping Chen, Ze Ping Zhou, Ren Chi Yang.   

Abstract

The family of T-cell immunoglobulin- and mucin-domain-containing molecules (TIMs) has an important role in immune regulation. TIM-3 is a transmembrane protein preferentially expressed on terminally differentiated Th1 cells and plays a role in T-helper (Th)-1-mediated autoimmune disease. Idiopathic thrombocytopenic purpura (ITP) is an acquired organ-specific autoimmune disease with a polarization of Th1. The purpose of this study was to investigate whether the -1516G>T, -574T>G, 4259G>T single-nucleotide polymorphisms within the TIM-3 gene contribute to the genetic susceptibility to ITP. Genotyping of TIM-3 -1516G>T, -574T>G, and 4259G>T was performed in 187 patients with ITP and 123 healthy individuals by polymerase chain reaction-restriction fragment length polymorphism assay. No significant differences existed in genotype and allele distributions between the patients with ITP and the controls in all three sites. There was strong linkage disequilibrium (LD; r(2) = 0.633) between -574T>G and 4259G>T, whereas -1516G>T was not in LD with -574T>G (r(2) = 0.007) or with 4259G>T (r(2) = 0.002). The -1516G>T, -574T>G, and 4259G>T of TIM-3 gene polymorphisms might not play an important role as a genetic risk factor in the pathophysiology of ITP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332093     DOI: 10.1016/j.humimm.2009.03.013

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

Review 1.  Genetic studies in pediatric ITP: outlook, feasibility, and requirements.

Authors:  Anke K Bergmann; Rachael F Grace; Ellis J Neufeld
Journal:  Ann Hematol       Date:  2010-03-23       Impact factor: 3.673

2.  Expression of human T cell immunoglobulin domain and mucin-3 on kidney tissue from immunoglobulin A nephropathy patients.

Authors:  Xiangdong Yang; Zhao Hu; Xiyan Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

3.  Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) on kidney tissue from systemic lupus erythematosus (SLE) patients.

Authors:  Ling Guo; Xiangdong Yang; Qing Xia; Junhui Zhen; Xuewei Zhuang; Tao Peng
Journal:  Clin Exp Med       Date:  2013-11-20       Impact factor: 3.984

Review 4.  TIM-3 as a new therapeutic target in systemic lupus erythematosus.

Authors:  Hai-Feng Pan; Ning Zhang; Wen-Xian Li; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

5.  Imbalanced expression of T-bet and T cell immunoglobulin mucin-3 in patients with aplastic anaemia.

Authors:  Ning-ning Shan; Yu Hu; Xin Liu; Xin Wang; Dai Yuan; Ying Li
Journal:  J Clin Immunol       Date:  2013-01-19       Impact factor: 8.317

6.  TIM-3 Rs10515746 (A/C) and Rs10053538 (C/A) Gene Polymorphisms and Risk of Multiple Sclerosis.

Authors:  Esmat Yaghoobi; Saeed Abedian; Omid Babani; Maryam Izad
Journal:  Iran J Public Health       Date:  2016-05       Impact factor: 1.429

7.  TIM-3 rs1036199 polymorphism increases susceptibility to autoimmune diseases: evidence based on 4200 subjects.

Authors:  Rongzeng Liu; Xing Wang; Xiafei Chen; Shengnan Wang; Heqian Zhang
Journal:  Biosci Rep       Date:  2018-11-23       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.